Microsponges: A novel strategy for drug delivery system

Journal of Advanced Pharmaceutical Technology and Research

Volumn 1, Issue 3, 2010, Pages 283-290

  Kaity, Santanu ^a   Maiti, Sabyasachi ^a   Ghosh, Ashoke Kumar ^b   Pal, Dilipkumar ^b   Ghosh, Animesh ^c   Banerjee, Subham ^b  

^a GUPTA COLLEGE OF TECHNOLOGICAL SCIENCES   (India)

^b Institute of Foreign Trade and Management   (India)

^c BIRLA INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Controlled release; drug delivery; healthcare systems; microsponges

Indexed keywords

AMMONIUM LACTATE; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; BENZOYL PEROXIDE; CHLORPHENIRAMINE; DIMETICONE; EUDRAGIT RS; FLUCONAZOLE; FLUOROURACIL; FLURBIPROFEN; HYDROQUINONE; IBUPROFEN; KETOPROFEN; METHACRYLIC ACID METHYL ESTER; MICROPEEL PLUS; MICROSPHERE; MICROSPONGE; POLYGLACTIN; POLYMER; POLYMETHACRYLIC ACID; RETIN A MICRO; RETINOIC ACID; RETINOL; RETINOL 15; SALICYLIC ACID; SALICYLIC PEEL 20; SALICYLIC PEEL 30; SPORTS CREAM RS; SPORTS CREAM XS; SUNSCREEN; ULTRA GUARD; UNCLASSIFIED DRUG;

ACNE; ACTINIC KERATOSIS; AQUEOUS SOLUTION; BIODEGRADABILITY; CREAM; DIAPER DERMATITIS; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG SAFETY; DRUG STABILITY; EMULSION; GEL; HUMAN; MUSCULOSKELETAL DISEASE; POLYMERIZATION; POROSITY; POWDER; PRIORITY JOURNAL; REVIEW; SKIN IRRITATION; SOLVENT EFFECT; SURFACE PROPERTY; TISSUE ENGINEERING;

EID: 79952969672     PISSN: 22314040     EISSN: 09762094     Source Type: Journal    
DOI: 10.4103/0110-5558.72416     Document Type: Review

References (40)

1. Saxena S, Nacht S. Polymeric porous delivery systems: Polytrap and Microsponge. In: Delivery System Handbook for Personal Care and Cosmetic Products: Technology, Applications and Formulations. New York: William Andrew Publishing; 2005. p. 333-51.
2. Kydonieus AF, Berner B. Transdermal Delivery of Drugs. Boca Raton: CRC Press; 1987.
3. Nacht S, Kantz M. The microsponge: A novel topical programmable delivery system. Top Drug Deliv Syst 1992;42:299-325.
4. Won R. Method for delivering an active ingredient by controlled time release utilizing a novel delivery vehicle which can be prepared by a process utilizing the active ingredient as a porogen. Patent No. 4690825. US: 1987.
5. Hainey P, Huxham IM, Rowatt B, Sherrington DC. Synthesis and ultrastructural studies, of styrene-divinylbenzene polyhipe polymers. Macromolecules 1991;24:117-21.
6. Orlu M, Cevher E, Araman A. Design and evaluation of colon specific drug delivery system containing flurbiprofen microsponges. Int J Pharm 2006; 318:103-17. (Pubitemid 43963308)
7. Embil K, Nacht S. The Microsponge delivery system (MDS): A topical delivery system with reduced irritancy incorporating multiple triggering mechanims for the release of actives. J Microencapsul 1996;13:575-88. (Pubitemid 26283810)
8. Martin A, Swarbrick J, Cammarrata A. Physical Pharmacy-Physical Chemical Principles in Pharmaceutical Sciences. 3 rd ed. Philadelphia: Lea and Febiger;1991. p. 527.
9. Emanuele AD, Dinarvand R. Preparation, Characterization and Drug Release from Thermo responsive Microspheres. Int J Pharmaceutics 1995;118:237-42.
10. Dsouza JI. The Microsponge Drug Delivery System: For Delivering an Active Ingredient by Controlled Time Release. Pharmaoinfo net 2008;6:3.
11. Washburn EW. Note on a method of determining the distribution of pore sizes in a porous material. Proc Natl Acad Sci U.S.A. 1921;7:115-6.
12. Orr Jr C. Application of mercury penetration to material analysis. Powder Technol 1969;3:117-23.
13. Kawashima Y, Niwa T, Takeuchi H, Hino T, Itoh Y, Furuyama S. Characterization of polymorphs of tranilast anhydrate and tranilast monohydrate when crystallized by two solvent change spherical crystallization techniques. J Pharm Sci 1991;81:472-8.
14. Bodmeier R, Chen H. Preparation and characterization of microspheres containing the anti-inflammatory agents, indomethacin, ibuprofen, and ketoprofen. J Control Release 1989;10:167-75. (Pubitemid 19259948)
15. Jones DS, Pearce KJ. Investigation of the effects of some process variables on, microencapsulation of propranolol HCl by solvent evaporation method. Int J Pharm 1995;118:99-205.
16. Juni K, Nakano M. Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetic. Chem Pharm Bull 1981;29:3363-8. (Pubitemid 12150769)
17. Barkai A, Pathak V, Benita S. Polyacrylate (Eudragit retard) microspheres for oral controlled release of nifedipine. I. Formulation design and process optimization. Drug Dev Ind Pharm 1990;16:2057-75. (Pubitemid 20300941)
18. Comolu T, Gnl N, Baykara T. Preparation and in vitro evaluation of modified release ketoprofen microsponge. Farmaco 2003;58:101-6. (Pubitemid 36197645)
19. Shah VP. Determination of In-vitro Release from Hydrocortisone Creams. Int J Pharm 1989;53:53-9. (Pubitemid 19160339)
20. Sato T, Kanke M, Schroeder G, Deluca P. Porous biodegradable microspheres for controlled drug delivery. I: Assessment of processing conditions and solvent removal techniques. Pharm Res 1988;5:21-30. (Pubitemid 18056894)
21. Draize JH, Woodard J, Calvary HO. Methods for the Study of Irritationand Toxicity of Substances Applied Topically to the Skin and Mucous Membranes. J Pharmacol and Exp Ther 1944;82:377-89.
22. Franz TJ. Percutaneous absorption. On the relevance of in vitro date. J Invest Dermatol 1975;45:498-503.
23. Yazici E, Kas HS, Hincal AA. Microsponges, Farmasotik Bilimler Dergisi (Turkey). 1994;19:121-8.
24. Wester R, Patel R, Natch S, Leyden J, Melendres J, Maibach H. Controlled release of benzoyl peroxide from a porous microsphere polymeric system can reduce topical irritancy. J Am Acad Derm 1991;24:720-6.
25. D'souza JI, Saboji JK, Killedar SG, More NH. Design and Evaluation of Benzoyl Peroxide Microsponges to Enhance Therapeutic Efficacy in Acne Treatment. 20 th FAPA Congress, Bangkok, Thailand: FAPA Congress; Nov 30-Dec 3, 2004.
26. D'souza JI. In-vitro Antibacterial and Skin Irritation Studies of Microsponges of Benzoyl Peroxide. Indian Drugs 2001;38:23.
27. Fincham JE, Karnik KA. Patient Counseling and Derm Therapy. US Pharm 1994;19:56-57, 61-2, 66, 71-2, 74, 77-8, 81-2.
28. D'souza JI, Masvekar RR, Pattekari PP, Pudi SR, More HN.Microspongic Delivery of Fluconazole For Topical Application, 1 st Indo-Japanese International Conference On Advances In Pharmaceutical Research And Technology. Mumbai, India: Pharmaceutical Research And Technology; 2005. p. 25-9.
29. Grimes PE. A microsponge formulation of hydroquinone 4% and retinol 0.15% in the treatment of melasma and post-inflammatory hyperpigmentation. Cutis 2004;74:362-8. (Pubitemid 40125978)
30. Embil VP. OTC External analgesic cream/topical analgesic-anti- inflammatory, counterirritant utilizing the Microsponge Delivery System (MDS) for controlled release of actives. Patent Application No: 0101058.6. UK: 2000.
31. Kawashima Y, Niwa T, Takeuchi H, Hino T, Itoh Y. Control of Prolonged Drug Release and Compression Properties of Ibuprofen Microsponges with Acrylic Polymer, Eudragit RS, by changing their Intraparticle Density. Chem Pharm Bull 1992;40:196-201.
32. Aritomi H, Yamasaki Y, Yamada K, Honda H, Koshi M. Development of sustained release formulation of chlorpheniramine maleate using powder coated microsponges prepared by dry impact blending method. J Pharm Sci Tech 1996;56:49-56.
33. OrluM, Cevher E, Araman A. Design and evaluation of colon specific drug delivery system containing flurbiprofen microsponges. Int J Pharm 2006;318:103-17. (Pubitemid 43963308)
34. Chen G, Ushida T, Tateishi T. A Biodegradable Hybrid Sponge Nested With Collagen Microsponges. J Biomed Mater Res 2000;51:273-9. (Pubitemid 30387644)
35. Kanematsu A, Marui A, Yamamoto S, Ozeki M, Hirano Y, Yamamoto M, et al. Type I collagen can function as a reservoir of basic fibroblast growth factor. J Control Release 2004;94:281-92. (Pubitemid 39222113)
36. Iwai S, Sawa Y, Ichikawa H, Taketani S, Uchimura E, Chen G, et al. Biodegradable polymer with collagen microsponge serves as a new bioengineered cardiovascular prosthesis. J Thorac Cardiovasc Surg 2004;128:472-9. (Pubitemid 39194708)
37. Chen G, Sato T, Ohgushi H, Ushida T, Tateishi T, Tanaka J. Culturing of skin fibroblasts in a thin PLGA-collagen hybrid mesh. Biomaterials 2005;26:2559-66. (Pubitemid 39600707)
38. Iwai S, Sawa Y, Taketani S, Torikai K, Hirakawa K, Matsuda H. Novel Tissue-Engineered Biodegradable Material for Reconstruction of Vascular Wall. Ann Thorac Surg 2005;80:1821-7. (Pubitemid 41464306)
39. Grimee PE, Meraz M. A new microentrapped 4% hydroquinone formulation for treatment of hyperpigmentation. 60 th Annual meeting of American Academy of Dermatology. La Poeter 519. New Orleane: Feb 22-27, 2002.
40. Khopade AJ, Jain S, Jain NK. The Microsponge. East Pharm 1996;39:49-53.